This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slivka, A. Search for Related Content PubMed PubMed Citation Articles by Slivka, A.

Stroke, Vol 22, 884-888, Copyright © 1991 by American Heart Association

ARTICLES

Effect of antihypertensive therapy on focal stroke in spontaneously hypertensive rats

A Slivka
Department of Neurology, Ohio State University, Columbus 43210.

Spontaneously hypertensive rats subjected to focal cerebral ischemia develop larger infarcts than normotensive rat strains. To determine whether antihypertensive therapy decreases infarct volume in hypertensive rats, 60 13-week-old animals were treated with 20 mg/kg hydralazine added daily to the drinking water for 1.5, 6, 10, or 16 weeks and then subjected to focal cerebral ischemia by tandem right common carotid artery and middle cerebral artery occlusion. Blood pressure in the treated groups was substantially lower than that in untreated groups after 1 week of hydralazine therapy and remained lower for the entire treatment period in all four experiments. Mean infarct volume in spontaneously hypertensive rats treated for 10 (p = 0.02) or 16 (p = 0.005) weeks, but not 1.5 or 6 weeks, was significantly less than that in the untreated controls. The percentage reduction of infarct volume in animals treated for 10 and 16 weeks was similar. This study demonstrates that antihypertensive therapy decreases infarct volume in hypertensive rats subjected to focal cerebral ischemia. This treatment effect appears to be dependent on the duration of therapy, and the magnitude of the treatment effect seems to plateau by 10 weeks of therapy.

This article has been cited by other articles:

				H. Yao, Z.-H. Cui, J. Masuda, and T. Nabika Congenic removal of a QTL for blood pressure attenuates infarct size produced by middle cerebral artery occlusion in hypertensive rats Physiol Genomics, June 19, 2007; 30(1): 69 - 73. [Abstract] [Full Text] [PDF]

				E. Tejima, Y. Katayama, Y. Suzuki, T. Kano, and E. H. Lo Hemorrhagic Transformation After Fibrinolysis With Tissue Plasminogen Activator : Evaluation of Role of Hypertension With Rat Thromboembolic Stroke Model Stroke, June 1, 2001; 32(6): 1336 - 1340. [Abstract] [Full Text] [PDF]

				G. A. Kidd, L. W. Dobrucki, V. Brovkovych, D. F. Bohr, and T. Malinski Nitric Oxide Deficiency Contributes to Large Cerebral Infarct Size Hypertension, May 1, 2000; 35(5): 1111 - 1118. [Abstract] [Full Text] [PDF]

				S. Rubattu, M. A. Lee-Kirsch, P. DePaolis, R. Giliberti, B. Gigante, A. Lombardi, M. Volpe, and K. Lindpaintner Altered Structure, Regulation, and Function of the Gene Encoding the Atrial Natriuretic Peptide in the Stroke-Prone Spontaneously Hypertensive Rat Circ. Res., November 12, 1999; 85(10): 900 - 905. [Abstract] [Full Text] [PDF]

				J. A. Gratton, A. Sauter, M. Rudin, K. R. Lees, J. McColl, J. L. Reid, A. F. Dominiczak, I. M. Macrae, and D. F. Bohr Susceptibility to Cerebral Infarction in the Stroke-Prone Spontaneously Hypertensive Rat Is Inherited as a Dominant Trait • Editorial Comment Stroke, March 1, 1998; 29(3): 690 - 694. [Abstract] [Full Text] [PDF]